Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,621 | 84,205 | 43,490 | 27,093 | 5,131 |
| Marketable Securities | 625 | 912 | N/A | N/A | N/A |
| Receivables | 1,293 | N/A | N/A | N/A | N/A |
| Inventories | 4,542 | 283 | N/A | N/A | N/A |
| Other current assets | 3,221 | 0 | 0 | 0 | 0 |
| TOTAL | $64,722 | $92,565 | $43,812 | $27,449 | $5,569 |
| Non-Current Assets | |||||
| PPE Net | 985 | 1,751 | 1,047 | 230 | 219 |
| Investments And Advances | 14,038 | 0 | 0 | 0 | 0 |
| Intangibles | 13,674 | 18,785 | 0 | 0 | 0 |
| Other Non-Current Assets | 9,212 | 310 | 242 | 35 | 38 |
| TOTAL | $37,909 | $20,846 | $1,289 | $264 | $257 |
| Total Assets | $102,631 | $113,411 | $45,101 | $27,713 | $5,826 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,113 | 968 | 4,316 | 1,065 | 884 |
| Accrued Expenses | 2,834 | 1,406 | 746 | 251 | 170 |
| TOTAL | $7,947 | $3,873 | $5,062 | $1,316 | $1,054 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 1,499 | 1,491 | 1,465 |
| Other Non-Current Liabilities | 21,019 | 74 | 0 | 4,122 | 9,395 |
| TOTAL | $21,689 | $74 | $1,499 | $5,614 | $10,860 |
| Total Liabilities | $29,636 | $3,947 | $6,561 | $6,929 | $11,914 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,902 | 9,572 | 7,964 | 6,020 | 4,258 |
| Common Shares | 979 | 954 | 699 | 603 | 325 |
| Retained earnings | -523,908 | -478,941 | -452,702 | -441,932 | -432,478 |
| Other shareholders' equity | -2,762 | -1,261 | -34 | -34 | -34 |
| TOTAL | $72,995 | $109,464 | $38,540 | $20,784 | $-6,087 |
| Total Liabilities And Equity | $102,631 | $113,411 | $45,101 | $27,713 | $5,826 |